• Academy Events

  • Harnessing the Potential of Genome Editing for Drug Discovery: Translational Frontiers of in vitro and in vivo Applications

    Tuesday, February 24, 2015 | 8:30 AM - 4:30 PM
    The New York Academy of Sciences

    Presented by the Biochemical Pharmacology Discussion Group

      • Registration Closed

    Until recently, the generation of precise alterations in mammalian genomes has been a challenging and cumbersome process. A rapid succession of technologies in the past several years has brought about a revolution in molecular biology: zinc-finger nucleases (ZFN), transcription activator-like effector nucleases (TALEN) and then clustered regularly interspaced short palindromic repeats (CRISPR). Each successive advancement has brought us closer to a routine, bench-level method to modify endogenous genetic elements. Now proof-of-concepts abound and encompass exciting frontiers such as rapid animal model development in addition to knockout and knock-in human and mouse cell lines. More recently, the framework of TALEN and CRISPR has been extended to a vast array of applications including epigenetic modulation, stimulation of gene expression, and targeted repression of gene transcription. What do these advances mean for drug discovery and translational research? This symposium will cover the latest techniques and methodologies in genome editing and the potential they hold for therapeutic development. In particular, the union of CRISPR and TALEN with stem and iPS cell technologies is an avenue that holds promise in improving the physiological relevance of disease models. However, the application of TALEN and CRIPSR to drug discovery is still in a nascent stage and innovation will be a core theme as we explore opportunities and current limitations.

    Call for Poster and Presentation Abstracts

    Abstract submissions are invited for a poster session, and several abstracts will be selected for short 'Late-breaking abstract' presentations. For complete submission instructions, please send an e-mail to with the words "Abstract Information" in the subject line. The deadline for abstract submission is February 3, 2015.

    *Networking Reception to follow.

    This event will also be broadcast as a webinar, for which you can register here.

    Please note: Transmission of presentations via the webinar is subject to individual consent by the speakers. Therefore, we cannot guarantee that every speaker's presentation will be broadcast in full via the webinar. To access all speakers' presentations in full, we invite you to attend the live event in New York City when possible.

    Registration and Webinar Pricing

    Member $30
    Student / Postdoc Member $15
    Nonmember (Academia) $65
    Nonmember (Corporate) $85
    Nonmember (Non-profit) $65
    Nonmember (Student / Postdoc / Resident / Fellow) $45

    The Biochemical Pharmacology Discussion Group is proudly supported by

    • Pfizer
    • Pfizer
    • Merck
    • Pfizer
    • WilmerHale

    Mission Partner support for the Frontiers of Science program provided by   Pfizer